The epidemiology of sudden death

Cardiac Arrest: The Science and Practice of Resuscitation Medicine

Volumn , Issue , 2007, Pages 26-48

  Nichol, Graham ^a   Baker, David ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889242238     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544828.004     Document Type: Chapter

References (231)

1. Last, J.M. Ed. A Dictionary of Epidemiology. Oxford, England: International Epidemiological Association, 2000.
2. Gillum, R.F. Sudden coronary death in the United States: 1980-1985. Circulation 1989; 79: 756-765.
3. Higgins, M.W., & Luepker, R.V. Trends in Coronary Heart Disease Mortality: The Influence of Medical Care. New York: Oxford University Press, 1988.
4. Rosamond, W.D., Chambless, L.E., Folsom, A.R. Et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Engl. J. Med. 1998; 339: 861-867.
5. Jacobs, I., Nadkarni, V., Bahr, J. Et al. Cardiac arrest and car-diopulmonary resuscitation outcome reports: Update and sim-plification of the Utstein templates for resuscitation registries: A statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation 2004; 110(21): 3385-3397.
6. Working Group on Ischemic Heart Disease Registers. Report of A Working Group. Parts I and II. Copenhagen, Denmark: Regional Office for Europe, World Health Organization, 1969.
7. Kurkciyan, I., Meron, G., Behringer, W. Et al. Accuracy and impact of presumed cause in patients with cardiac arrest. Circulation 1998; 98(8): 766-771.
8. Uretsky, B.F., Thygesen, K., Armstrong, P.W. Et al. Acute coro-nary findings at autopsy in heart failure patients with sudden death: Results from the assessment of treatment with lisino-pril and survival (ATLAS) trial. Circulation 2000; 102(6): 611-616.
9. Soo, L.H., Gray, D., & Hampton, J.R. Pathological features of witnessed out-of-hospital cardiac arrest presenting with ven-tricular fibrillation. Resuscitation 2001; 51(3): 257-264.
10. Yusuf, S., Reddy, S., Ounpuu, S., & Anand, S. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urban-ization. Circulation 2001; 104(22): 2746-2753.
11. Anonymous. World Health Report 2002: Reducing Risks and Promoting Healthy Life. Geneva: World Health Organization, 2002.
12. Mathers, C.D., Stein, C., Fat Ma, D. Et al. Global Burden of Disease 2000. Version 2: Methods and Results. Geneva: World Health Organization, 2002.
13. Myerburg, R.J., Kessler, K.M., & Castellanos, A. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann. Intern. Med. 1993; 119(12): 1187-1197.
14. Rea, T.D., Pearce, R.M., Raghunathan, T.E. Et al. Incidence of out-of-hospital cardiac arrest. Am. J. Cardiol. 2004; 93(12): 1455-1460.
15. Chugh, S.S., Jui, J., Gunson, K. Et al. Current burden of sudden cardiac death: Multiple source surveillance versus retrospec-tive death certificate-based review in a large U.S. Community. J. Am. Coll. Cardiol. 2004; 44(6): 1268-1275.
16. Sayre, M.R., Travers, A.H., Daya, M. Et al. Measuring survival rates from sudden cardiac arrest: The elusive definition. Resuscitation 2004; 62(1): 25-34.
17. Eisenberg, M.S., Cummins, R.O., & Larsen, M.P. Numerators, denominators and survival rates: Reporting survival from out-of-hospital cardiac arrest. Am. J. Emerg. Med. 1991; 9: 544-546.
18. Martens, P., Mullie, A., Calle, P., Van Hoeyweghen, R., & Group, B.C.R.S. Influence on outcome after cardiac arrest of time elapsed between call for help and start of bystander basic CPR. Resuscitation 1993; 25: 227-234.
19. Valenzuela, T.D., Spaite, D.W., Meislin, H.W., Clark, L.L., Wright, A.L., & Ewy, GA. Emergency vehicle intervals versus collapse-to-CPR and collapse-to-defibrillation intervals: Monitoring emergency medical services system performance in sudden cardiac arrest. Ann. Emerg. Med. 1993; 22(11): 1678-1683.
20. Wik, L., Steen, P., & Bircher, N. Quality of bystander car-diopulmonary resuscitation influences outcome after pre-hospital cardiac arrest. Resuscitation 1994; 28: 195-203.
21. Fox, C.S., Evans, J.C., Larson, M.G. Et al. A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am. J. Cardiol. 2005; 95(7): 856-859.
22. Zheng, Z.J., Croft, J.B., Giles, W.H., & Mensah, G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104(18): 2158-2163.
23. Cummins, R.O., & Graves, J.R. Cardiopulmonary resuscita-tion: Clinics in critical care medicine. In Kaye, W., & Bircher, N., eds. Cardiopulmonary Resuscitation: Clinics in Critical Care Medicine. New York: Churchill-Livingstone, 1989.
24. Holmberg, M., Holmberg, S., Herlitz, J., & Gardelov, B. Survival after cardiac arrest outside hospital in Sweden. Swedish Cardiac Arrest Registry. Resuscitation 1998; 36(1): 29-36.
25. Cobbe, S.M., Redmond, M.J., Watson, J.M., Hollingworth, J., & Carrington, D.J. “Heartstart Scotland”-initial experience of a national scheme for out of hospital defibrillation. Br. Med. J. 1991; 302(6791): 1517-1520.
26. Nichol, G., Steen, P., Herlitz, J. Et al. International Resuscitation Network Registry: Design, rationale and pre-liminary results. Resuscitation 2005; 65(3): 265-277.
27. Weisfeldt, M.L., & Becker, L.B. Resuscitation after cardiac arrest: A 3-phase time-sensitive model. J. Am. Med. Assoc. 2002; 288(23): 3035-3038.
28. Valenzuela, T.D., Roe, D.J., Nichol, G., Clark, L.L., Spaite, D.W., & Hardman, R.G. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N. Engl. J. Med. 2000; 343(17): 1206-1209.
29. Martinez-Rubio, A., Kanaan, N., Borggrefe, M. Et al. Advances for treating in-hospital cardiac arrest: Safety and effective-ness of a new automatic external cardioverter-defibrillator. J. Am. Coll. Cardiol. 2003; 41(4): 627-632.
30. Morrison, L.J., Dorian, P., Long, J. Et al. Out-of-hospital cardiac arrest rectilinear biphasic to monophasic damped sine defib-rillation waveforms with advanced life support intervention trial (ORBIT). Resuscitation 2005; 66(2): 149-157.
31. van Alem, A.P., Vrenken, R.H., de Vos, R., Tijssen, J.G., & Koster, R.W. Use of automated external defibrillator by first respon-ders in out of hospital cardiac arrest: Prospective controlled trial. Br. Med. J. 2003; 327(7427): 1312.
32. Hallstrom, A.P. Should time from cardiac arrest until call to emergency medical services (EMS) be collected in EMS research? Crit. Care Med. 2002; 30(4 Suppl): S127-S130.
33. Ornato, J.P., Doctor, M.L., Harbour, L.F. Et al. Synchronization of timepieces to the atomic clock in an urban emergency medical services system. Ann. Emerg. Med. 1998; 31(4): 483-487.
34. Lombardi, G., Gallagher, J., & Gennis, P. Outcome of out-of-hospital cardiac arrest in New York City. The Pre-Hospital Arrest Survival Evaluation (PHASE) Study. J. Am. Med. Assoc. 1994; 271(9): 678-683.
35. Valenzuela, T.D., Spaite, D.W., Meislin, H.W., Wright, A.L., & Ewy, G.A. Emergency vehicle intervals versus collapse-to-CPR and collapse-to-defibrillation intervals: Monitoring emergency medical services system performance in sudden cardiac arrest. Ann. Emerg. Med. 1993; 22: 1678-1683.
36. Sunde, K., Eftestol, T., Askenberg, C., & Steen, P.A. Quality assessment of defribrillation and advanced life support using data from the medical control module of the defibrillator. Resuscitation 1999; 41(3): 237-247.
37. Valenzuela, T.D., Kern, K.B., Clark, L.L. Et al. Interruptions of chest compressions during emergency medical systems resuscitation. Circulation 2005; 112(9): 1259-1265.
38. Everett, T.H.4th., Wilson, E.E., Foreman, S., & Olgin, J.E. Mechanisms of ventricular fibrillation in canine models of congestive heart failure and ischemia assessed by in vivo noncontact mapping. Circulation 2005; 112(11): 1532-1541.
39. Brown, C.G., Dzwonczyk, R., & Martin, D.R. Physiologic measurement of the ventricular fibrillation ECG signal: Esti-mating the duration of ventricular fibrillation. Ann. Emerg. Med. 1993; 22(1): 70-74.
40. Lightfoot, C.B., Nremt, P., Callaway, C.W. Et al. Dynamic nature of electrocardiographic waveform predicts rescue shock outcome in porcine ventricular fibrillation. Ann. Emerg. Med. 2003; 42(2): 230-241.
41. Berg, R.A., Hilwig, R.W., Kern, K.B., & Ewy, G.A. Precountershock cardiopulmonary resuscitation improves ventricular fibrillation median frequency and myocardial readiness for successful defibrillation from prolonged ven-tricular fibrillation: A randomized, controlled swine study. Ann. Emerg. Med. 2002; 40(6): 563-570.
42. Callaway, C.W., Sherman, L.D., Mosesso, V.N., Jr., Dietrich, T.J., Holt, E., & Clarkson, M.C. Scaling exponent predicts defibrillation success for out-of-hospital ventricular fibrilla-tion cardiac arrest. Circulation 2001; 103(12): 1656-1661.
43. Jekova, I., Dushanova, J., & Popivanov, D. Method for ventricu-lar fibrillation detection in the external electrocardiogram using nonlinear prediction. Physiol. Meas. 2002; 23(2): 337-345.
44. Eftestol, T., Sunde, K., & Steen, P.A. Effects of interrupting pre-cordial compressions on the calculated probability of defib-rillation success during out-of-hospital cardiac arrest. Circulation 2002; 105(19): 2270-2273.
45. Maldonado, F.A., Weil, M.H., Tang, W. Et al. Myocardial hyper-carbic acidosis reduces cardiac resuscitability. Anesthesiology 1993; 78(2): 343-352.
46. Jin, X., Weil, M.H., Tang, W. Et al. End-tidal carbon dioxide as a noninvasive indicator of cardiac index during circulatory shock. Crit. Care Med. 2000; 28(7): 2415-2419.
47. Pernat, A., Weil, M.H., Tang, W. Et al. Effects of hyper-and hypoventilation on gastric and sublingual PCO2. J. Appl. Physiol. 1999; 87(3): 933-937.
48. Pirrallo, R.G., Swor, R.A., & Maio, R.F. Inter-rater agreement of paramedic rhythm labeling. Ann. Emerg. Med. 1993; 22(11): 1684-1687.
49. Macdonald, R.D., Swanson, J.M., Mottley, J.L., & Weinstein, C. Performance and error analysis of automated external defib-rillator use in the out-of-hospital setting. Ann. Emerg. Med. 2001; 38(3): 262-267.
50. Cobb, L.A., Fahrenbruch, C.E., Olsufka, M., & Copass, M.K. Changing incidence of out-of-hospital ventricular fibrilla-tion, 1980-2000. J. Am. Med. Assoc. 2002; 288(23): 3008-3013.
51. de Vreede-Swagemakers, J.J., Gorgels, A.P., Dubois-Arbouw, W.I. Et al. Out-of-hospital cardiac arrest in the 1990's: A pop-ulation-based study in the Maastricht area on incidence, characteristics and survival. J. Am. Coll. Cardiol. 1997; 30(6): 1500-1505.
52. Reddy, K.S., & Yusuf, S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97(6): 596-601.
53. Tillinghast, S.J., Doliszny, K.M., Gomez-Marin, O., Lilja, G.P., & Campion, B.C. Change in survival from out-of-hospital cardiac arrest and its effect on coronary heart disease mortality-Minneapolis-St. Paul: The Minnesota Heart Survey. Am. J. Epidemiol. 1991; 134(8): 851-861.
54. Rea, T.D., Eisenberg, M.S., Becker, L.J., Murray, J.A., & Hearne, T. Temporal trends in sudden cardiac arrest: A 25-year emer-gency medical services perspective. Circulation 2003; 107(22): 2780-2785.
55. Herlitz, J., Bang, A., Gunnarsson, J. Et al. Factors associated with survival to hospital discharge among patients hospi-talised alive after out of hospital cardiac arrest: Change in outcome over 20 years in the community of Goteborg, Sweden. Heart 2003; 89(1): 25-30.
56. Donoghue, A., Nadkarni, V., Berg, R.A. Et al. Out-of-hospital pediatric cardiac arrest: An epidemiologic review and assess-ment of current knowledge. Ann. Emerg. Med. 2005; 46(6): 512-522.
57. Young, K.D., Gausche-Hill, M., McClung, C.D., & Lewis, R.J. A prospective, population-based study of the epidemiology and outcome of out-of-hospital pediatric cardiopulmonary arrest. Pediatrics 2004; 114(1): 157-164.
58. Mogayzel, C., Quan, L., Graves, L., Teidman, D., Fahrenbruch, C., & Herndon, P. Out-of-hospital ventricular fibrillation in children and adolescents: Causes and outcomes. Ann. Emerg. Med. 1995; 25: 484-491.
59. Peberdy, M.A., Kaye, W., Ornato, J.P. Et al. Cardiopulmonary resuscitation of adults in the hospital: A report of 14, 720 cardiac arrest from the National Registry of Cardiopulmonary Resuscitation. Resuscitation 2003; 58: 297-308.
60. Huikuri, H.V., Castellanos, A., & Myerburg, R.J. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. 2001; 345(20): 1473-1482.
61. Eisenberg, M.S., Cummins, R.O., Damon, S., Larsen, M.P., & Hearne, T.R. Survival rates from out-of-hospital cardiac arrest: Recommendations for uniform definitions and data to report. Ann. Emerg. Med. 1990; 19: 1249-1259.
62. Holmberg, M., Holmberg, S., & Herlitz, J. An alternate esti-mate of the disappearance rate of ventricular fibrillation in out-of-hospital cardiac arrest in Sweden. Resuscitation 2001; 49: 219-220.
63. Leaf, A., Kang, J.X., Xiao, Y.F., & Billman, G.E. Clinical preven-tion of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107(21): 2646-2652.
64. Roden, D.M., & Yang, T. Protecting the heart against arrhyth-mias: Potassium current physiology and repolarization reserve. Circulation 2005; 112(10): 1376-1378.
65. Albert, C.M., Ma, J., Rifai, N., Stampfer, M.J., & Ridker, P.M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105(22): 2595-2599.
66. Kumari, M., Marmot, M., & Brunner, E. Social determinants of von willebrand factor: The Whitehall II study. Arterioscler. Thromb. Vasc. Biol. 2000; 20(7): 1842-1847.
67. Siscovick, D.S., Lemaitre, R.N., & Mozaffarian, D. The fish story: A diet-heart hypothesis with clinical implications: N-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death. Circulation 2003; 107(21): 2632-2634.
68. Jouven, X., Desnos, M., Guerot, C., & Ducimetiere, P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation 1999; 99(15): 1978-1983.
69. Spooner, P.M., Albert, C., Benjamin, E.J. Et al. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II. Circulation 2001; 103(20): 2447-2452.
70. Spooner, P.M., Albert, C., Benjamin, E.J. Et al. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 2001; 103(19): 2361-2364.
71. Tan, H.L., Hofman, N., van Langen, I.M., van der Wal, A.C., & Wilde, A.A. Sudden unexplained death: Heritability and diag-nostic yield of cardiological and genetic examination in sur-viving relatives. Circulation 2005; 112(2): 207-213.
72. Friedlander, Y., Siscovick, D.S., Weinmann, S. Et al. Family history as a risk factor for primary cardiac arrest. Circulation 1998; 97(2): 155-160.
73. Priori, S.G., Barhanin, J., Hauer, R.N. Et al. Genetic and mole-cular basis of cardiac arrhythmias: Impact on clinical man-agement parts I and II. Circulation 1999; 99(4): 518-528.
74. Schwartz, P.J., Priori, S.G., Spazzolini, C. Et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103(1): 89-95.
75. Page, R.L., Zipes, D.P., Powell, J.L. Et al. Seasonal variation of mortality in the antiarrhythmics versus implantable defibril-lators (AVID) study registry. Heart Rhythm 2004; 1(4): 435-440.
76. Anonymous. Fall-related injuries during the holiday season-United States, 2000-2003. Morb. Mortal. Wkly Rep. 2004; 53(48): 1127-1129.
77. Crawford, J.R., & Parker, M.J. Seasonal variation of proximal femoral fractures in the United Kingdom. Injury 2003; 34(3): 223-225.
78. Allegra, J.R., Cochrane, D.G., Allegra, E.M., & Cable, G. Calendar patterns in the occurrence of cardiac arrest. Am. J. Emerg. Med. 2002; 20(6): 513-517.
79. Herlitz, J., Eek, M., Holmberg, M., & Holmberg, S. Diurnal, weekly and seasonal rhythm of out of hospital cardiac arrest in Sweden. Resuscitation 2002; 54(2): 133-138.
80. Gruska, M., Gaul, G.B., Winkler, M. Et al. Increased occur-rence of out-of-hospital cardiac arrest on Mondays in a com-munity-based study. Chronobiol. Int 2005; 22(1): 107-120.
81. Becker, L.B., Han, B.H., Meyer, P.M. Et al. Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N. Engl. J. Med. 1993; 329(9): 600-606.
82. Iwashyna, T.J., Christakis, N.A., & Becker, L.B. Neighborhoods matter: A population-based study of provision of cardiopul-monary resuscitation. Ann. Emerg. Med. 1999; 34(4 Pt 1): 459-468.
83. Sampson, R.J., Raudenbush, S.W., & Earls, F. Neighborhoods and violent crime: A multilevel study of collective efficacy. Science 1997; 277(5328): 918-924.
84. Sampson, R.J., Morenoff, J.D., & Raudenbush, S. Social anatomy of racial and ethnic disparities in violence. Am. J. Public. Health 2005; 95(2): 224-232.
85. Dunn, L., Henry, J., & Beard, D. Social deprivation and head injury: A national study. J. Neurol. Neurosurg. Psychiatry 2003; 74(8): 1060-1064.
86. Cubbin, C., LeClere, F.B., & Smith, G.S. Socioeconomic status and the occurrence of fatal and nonfatal injury in the United States. Am. J. Public Health 2000; 90(1): 70-77.
87. Cubbin, C., LeClere, F.B., & Smith, G.S. Socioeconomic status and injury mortality: Individual and neighbourhood deter-minants. J. Epidemiol. Commun. Hlth. 2000; 54(7): 517-524.
88. Singh, G.K., & Siahpush, M. Increasing inequalities in all-cause and cardiovascular mortality among US adults aged 25-64 years by area socioeconomic status, 1969-1998. Int. J. Epidemiol. 2002; 31(3): 600-613.
89. Wilkins, R., Berthelot, J.-M., & Ng, E. Trends in mortality by neighbourhood income in urban Canada from 1971 to 1996. Health Reports 2002(Dec. 11).
90. Anonymous. Health disparities experienced by black or African Americans-United States. Morb. Mortal. Wkly Rep. 2005; 54(1): 1-3.
91. Anonymous. Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. Morb. Mortal. Wkly Rep. 2005; 54(25): 625-628.
92. Mehta, M.C., Jain, A.C., Mehta, A., & Billie, M. Cardiac arrhythmias following intravenous nicotine: Experimental study in dogs. J. Cardiovasc. Pharmacol. Ther. 1997; 2(4): 291-298.
93. Jamrozik, K. Estimate of deaths attributable to passive smoking among UK adults: Database analysis. Br. Med. J. 2005; 330(7495): 812.
94. Berlin, J.A., & Colditz, G.A. A meta-analysis of physical activ-ity in the prevention of coronary heart disease. Am. J. Epidemiol. 1990; 132(4): 612-628.
95. Taylor, R.S., Brown, A., Ebrahim, S. Et al. Exercise-based reha-bilitation for patients with coronary heart disease: Systematic review and meta-analysis of randomized controlled trials. Am. J. Med. 2004; 116(10): 682-692.
96. Mittleman, M.A., Maclure, M., Tofler, G.H., Sherwood, J.B., Goldberg, R.J., & Muller, J.E. Triggering of acute myocardial infarction by heavy physical exertion. Protection against trig-gering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N. Engl. J. Med. 1993; 329(23): 1677-1683.
97. Moliterno, D.J., Willard, J.E., Lange, R.A. Et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N. Engl. J. Med. 1994; 330(7): 454-459.
98. Paredes, V.L., Rea, T.D., Eisenberg, M.S. Et al. Out-of-hospital care of critical drug overdoses involving cardiac arrest. Acad. Emerg. Med. 2004; 11(1): 71-74.
99. Krantz, M.J., Rowan, S.B., & Mehler, P.S. Cocaine-related torsade de pointes in a methadone maintenance patient. J. Addict. Dis. 2005; 24(1): 53-60.
100. Gaziano, J.M., Buring, J.E., Breslow, J.L. Et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarc-tion. N. Engl. J. Med. 1993; 329(25): 1829-1834.
101. Kupari, M., & Koskinen, P. Alcohol, cardiac arrhythmias and sudden death. Novartis Found Symp. 1998; 216: 68-79.
102. Albert, C.M., Manson, J.E., Cook, N.R., Ajani, U.A., Gaziano, J.M., & Hennekens, C.H. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 1999; 100(9): 944-950.
103. Wannamethee, G., & Shaper, A.G. Alcohol and sudden cardiac death. Br. Heart J. 1992; 68(5): 443-448.
104. Mittleman, M.A., Maclure, M., Nachnani, M., Sherwood, J.B., & Muller, J.E. Educational attainment, anger, and the risk of triggering myocardial infarction onset. The Determinants of Myocardial Infarction Onset Study Investigators. Arch. Intern. Med. 1997; 157(7): 769-775.
105. Anonymous. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. N. Engl. J. Med. 1996; 335(11): 775-782.
106. Alexander, J.H., Sparapani, R.A., Mahaffey, K.W. Et al. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syn-dromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. J. Am. Med. Assoc. 2000; 283(3): 347-353.
107. Califf, R.M., Pieper, K.S., Lee, K.L. Et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 2000; 101(19): 2231-2238.
108. Pinski, S.L., Yao, Q., Epstein, A.E. Et al. Determinants of outcome in patients with sustained ventricular tachyarrhyth-mias: The antiarrhythmics versus implantable defibrillators (AVID) study registry. Am. Heart J. 2000; 139(5): 804-813.
109. Moss, A.J., DeCamilla, J., & Davis, H. Cardiac death in the first 6 months after myocardial infarction: Potential for mortality reduction in the early posthospital period. Am. J. Cardiol. 1977; 39(6): 816-820.
110. Bailey, J.J., Berson, A.S., Handelsman, H., & Hodges, M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J. Am. Coll. Cardiol. 2001; 38(7): 1902-1911.
111. La Rovere, M.T., Bigger, J.T., Jr., Marcus, F.I., Mortara, A., & Schwartz, P.J., for the ATRAMI Investigators. Baroflex sensi-tivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478-484.
112. Thompson, R.G., & Cobb, L.A. Hypokalemia after resuscita-tion from out-of-hospital ventricular fibrillation. J. Am. Med. Assoc. 1982; 248(21): 2860-2863.
113. Estes, N.A., 3rd, Link, M.S., Cannom, D. Et al. Report of the NASPE policy conference on arrhythmias and the athlete. J. Cardiovasc. Electrophysiol. 2001; 12(10): 1208-1219.
114. Lewington, S., Clarke, R., Qizilbash, N., Peto, R., & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-1913.
115. Castelli, W.P. Epidemiology of coronary heart disease: The Framingham study. Am. J. Med. 1984; 76(2A): 4-12.
116. Fields, L.E., Burt, V.L., Cutler, J.A., Hughes, J., Roccella, E.J., & Sorlie, P. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension 2004; 44(4): 398-404.
117. Vasan, R.S., Beiser, A., Seshadri, S. Et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. J. Am. Med. Assoc. 2002; 287(8): 1003-1010.
118. Hajjar, I., & Kotchen, T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. J. Am. Med. Assoc. 2003; 290(2): 199-206.
119. Psaty, B.M., Lumley, T., Furberg, C.D. Et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. J. Am. Med. Assoc. 2003; 289(19): 2534-2544.
120. Stamler, J., Wentworth, D., & Neaton, J.D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J. Am. Med. Assoc. 1986; 256(20): 2823-2828.
121. Castelli, W.P. The triglyceride issue: A view from Framingham. Am. Heart J. 1986; 112(2): 432-437.
122. Gould, K.L., Ornish, D., Kirkeeide, R. Et al. Improved stenosis geometry by quantitative coronary arteriography after vigor-ous risk factor modification. Am. J. Cardiol. 1992; 69(9): 845-853.
123. Hooper, L., Summerbell, C.D., Higgins, J.P.T. Et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev. 2005(3).
124. Flegal, K.M., Carroll, M.D., Kuczmarski, R.J., & Johnson, C.L. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int. J. Obes. Relat. Metab. Disord. 1998; 22(1): 39-47.
125. Flegal, K.M., Carroll, M.D., Ogden, C.L., & Johnson, C.L. Prevalence and trends in obesity among US adults, 1999-2000. J. Am. Med. Assoc. 2002; 288(14): 1723-1727.
126. Mokdad, A.H., Serdula, M.K., Dietz, W.H., Bowman, B.A., Marks, J.S., & Koplan, J.P. The spread of the obesity epidemic in the United States, 1991-1998. J. Am. Med. Assoc. 1999; 282(16): 1519-1522.
127. Gregg, E.W., Cheng, Y.J., Cadwell, B.L. Et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. J. Am. Med. Assoc. 2005; 293(15): 1868-1874.
128. Mokdad, A.H., Bowman, B.A., Ford, E.S., Vinicor, F., Marks, J.S., & Koplan, J.P. The continuing epidemics of obesity and diabetes in the United States. J. Am. Med. Assoc. 2001; 286(10): 1195-1200.
129. Karnik, J.A., Young, B.S., Lew, N.L. Et al. Cardiac arrest and sudden death in dialysis units. Kidney Int. 2001; 60(1): 350-357.
130. Michal, V. Arterial disease as a cause of impotence. Clin. Endocrinol. Metab. 1982; 11(3): 725-748.
131. Wabrek, A.J., & Burchell, R.C. Male sexual dysfunction associ-ated with coronary heart disease. Arch. Sex Behav. 1980; 9(1): 69-75.
132. Connolly, S.J., Hallstrom, A.P., Cappato, R. Et al. Meta-analysis of the implantable cardioverter defibrillator secondary pre-vention trials. Eur. Heart J. 2000; 21(24): 2071-2078.
133. Hohnloser, S.H., Kuck, K.H., Dorian, P. Et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med. 2004; 351(24): 2481-2488.
134. Feldman, A.M., Klein, H., Tchou, P. Et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: Results of the WEARIT/BIROAD. Pacing Clin. Electrophysiol. 2004; 27(1): 4-9.
135. Parkash, R., Tang, A., Wells, G. Et al. Use of implantable car-dioverter defibrillators after out-of-hospital cardiac arrest: A prospective follow-up study. CMAJ. 2004; 171(9): 1053-1056.
136. Alberte, C., Zipes, D.P. Use of nonantiarrhythmic drugs for prevention of sudden cardiac death. J. Cardiovasc. Electro-physiol. 2003; 14(9 Suppl): S87-S95.
137. Fletcher, R.D., Cintron, G.B., Johnson, G., Orndorff, J., Carson, P., & Cohn, J.N. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. Circulation 1993; 87(6 Suppl): VI49-VI55.
138. Schrier, R.W., & Abraham, W.T. Hormones and hemodynam-ics in heart failure. N. Engl. J. Med. 1999; 341(8): 577-585.
139. Elfellah, M.S., & Ogilvie, R.I. Effect of vasodilator drugs on coronary occlusion and reperfusion arrhythmias in anes-thetized dogs. J. Cardiovasc. Pharmacol. 1985; 7(5): 826-832.
140. Domanski, M.J., Exner, D.V., Borkowf, C.B., Geller, N.L., Rosenberg, Y., & Pfeffer, M.A. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients follow-ing acute myocardial infarction. A meta-analysis of random-ized clinical trials. J. Am. Coll. Cardiol. 1999; 33(3): 598-604.
141. Pitt, B., Zannad, F., Remme, W.J. Et al. The effect of spirono-lactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 1999; 341(10): 709-717.
142. Mann, D.L., Kent, R.L., Parsons, B., & Cooper, G.4th. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992; 85(2): 790-804.
143. Eichhorn, E.J., & Bristow, M.R. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 1996; 94(9): 2285-2296.
144. Anonymous. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. Lancet 1997; 349(9049): 375-380.
145. Packer, M., Bristow, M.R., Cohn, J.N. Et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med. 1996; 334: 1349-1355.
146. Anonymous. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353(9169): 2001-2007.
147. Anonymous. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999; 353(9146): 9-13.
148. Domanski, M.J., Krause-Steinrauf, H., Massie, B.M. Et al. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J. Card. Fail. 2003; 9(5): 354-363.
149. Dimmeler, S., Haendeler, J., Galle, J., & Zeiher, A.M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the ‘response to injury’ hypothesis. Circulation 1997; 95(7): 1760-1763.
150. Hassall, D.G., Owen, J.S., & Bruckdorfer, K.R. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J. 1983; 216(1): 43-49.
151. Ridker, P.M., & Haughie, P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J. Investig. Med. 1998; 46(8): 391-395.
152. LaRosa, J.C., He, J., & Vupputuri, S. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. J. Am. Med. Assoc. 1999; 282(24): 2340-2346.
153. Anonymous. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360(9326): 7-22.
154. Sweeney, M.O., Moss, A.J., & Eberly, S. Instantaneous cardiac death in the posthospital period after acute myocardial infarction. Am. J. Cardiol. 1992; 70(18): 1375-1379.
155. Anonymous. The effect of digoxin on mortality and morbid-ity in patients with heart failure. The Digitalis Investigation Group. N. Engl. J. Med. 1997; 336(8): 525-533.
156. Packer, M., Carver, J.R., Rodeheffer, R.J. Et al. Effect of oral mil-rinone on mortality in severe chronic heart failure. N. Engl. J. Med. 1991; 325: 1468-1475.
157. Kubo, S.H., Gollub, S., Bourge, R. Et al. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group. Circulation 1992; 85(3): 942-949.
158. Massie, B.M., Berk, M.R., Brozena, S.C. Et al. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). Circulation 1993; 88(2): 492-501.
159. Cohn, J.N., Goldstein, S.O., Greenberg, B.H. Et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N. Engl. J. Med. 1998; 339(25): 1810-1816.
160. Anonymous. Preliminary report: Effect of encainide and fle-cainide on mortality in a randomized trial of arrhythmia sup-pression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N. Engl. J. Med. 1989; 321(6): 406-412.
161. Anonymous. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators. N. Engl. J. Med. 1992; 327(4): 227-233.
162. Waldo, A.L., Camm, A.J., deRuyter, H. Et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996; 348(9019): 7-12.
163. Torp-Pedersen, C., Moller, M., Bloch-Thomsen, P.E. Et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N. Engl. J. Med. 1999; 341(12): 857-865.
164. Doval, H.C., Nul, D.R., Grancelli, H.O., Perrone, S.V., Bortman, G.R., & Curiel, R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994; 344(8921): 493-498.
165. Nicklas, J.M., McKenna, W.J., Stewart, R.A. Et al. Prospective, double-blind, placebo-controlled trial of low-dose amio-darone in patients with severe heart failure and asympto-matic frequent ventricular ectopy. Am. Heart J. 1991; 122(4 Pt 1): 1016-1021.
166. Cairns, J.A., Connolly, S.J., Roberts, R., & Gent, M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators [published erratum appears in Lancet 1997 Jun 14; 349(9067): 1776] [see com-ments]. Lancet 1997; 349(9053): 675-682.
167. Julian, D.G., Camm, A.J., Frangin, G. Et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997; 349(9053): 667-674.
168. Burkart, F., Pfisterer, M., Kiowski, W., Follath, F., & Burckhardt, D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ven-tricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J. Am. Coll. Cardiol. 1990; 16(7): 1711-1718.
169. Ceremuzynski, L., Kleczar, E., Krzeminska-Pakula, M. Et al. Effect of amiodarone on mortality after myocardial infarc-tion: A double-blind, placebo-controlled, pilot study. J. Am. Coll. Cardiol. 1992; 20(5): 1056-1062.
170. Pfisterer, M., Kiowski, W., Burckhardt, D., Follath, F., & Burkart, F. Beneficial effect of amiodarone on cardiac mortal-ity in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am. J. Cardiol. 1992; 69(17): 1399-1402.
171. Anonymous. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet 1997; 350(9089): 1417-1424.
172. Greene, H.L. The CASCADE Study: Randomized antiarrhyth-mic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. Am. J. Cardiol. 1993; 72(16): 70F-74F.
173. Tsutamoto, T., Wada, A., Maeda, K. Et al. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necro-sis factor alpha, interleukin-6 and soluble adhesion mole-cules in patients with chronic heart failure. J. Am. Coll. Cardiol. 2000; 35(3): 714-721.
174. Goodfield, N.E., Newby, D.E., Ludlam, C.A., & Flapan, A.D. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation 1999; 99(23): 2983-2985.
175. Pitt, B. Evaluation of Losartan in the Elderly (ELITE) Trial: Clinical implications. Eur. Heart J. 1997; 18(8): 1197-1199.
176. Pitt, B., Poole-Wilson, P.A., Segal, R. Et al. Effect of losartan compared with captopril on mortality in patients with symp-tomatic heart failure: Randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355(9215): 1582-1587.
177. Dickstein, K., & Kjekshus, J. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: The OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 2002; 360(9335): 752-760.
178. Marcus, F.I., Cobb, L.A., Edwards, J.E. Et al. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am. J. Cardiol. 1988; 61(1): 8-15.
179. Anonymous. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994; 343: 311-322.
180. Cohen, M., Demers, C., Gurfinkel, E.P. Et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N. Engl. J. Med. 1997; 337(7): 447-452.
181. Kong, D.F., Califf, R.M., Miller, D.P. Et al. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation 1998; 98(25): 2829-2835.
182. Yusuf, S., Zhao, F., Mehta, S.R., Chrolavicius, S., Tognoni, G., & Fox, K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 2001; 345(7): 494-502.
183. Anonymous. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Br. Med. J. 1994; 308(6921): 81-106.
184. Anand, S.S., & Yusuf, S. Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis. J. Am. Med. Assoc. 1999; 282(21): 2058-2067.
185. Eisenberg, M.S., Horwood, B.T., Cummins, R.O., Reynolds-Haertle, R., & Hearne, T.R. Cardiac arrest and resuscitation: A tale of 29 cities. Ann. Emerg. Med. 1990; 19: 179-186.
186. Nichol, G., Stiell, I.G., Laupacis, A., Pham, B., De Maio, V., & Wells, G.A. A cumulative metaanalysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann. Emerg. Med. 1999; 34(4): 517-525.
187. Anonymous. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N. Engl. J. Med. 2004; 351(7): 637-646.
188. Soo, L.H., Gray, D., Young, T., Skene, A., & Hampton, J.R. Influence of ambulance crew's length of experience on the outcome of out-of-hospital cardiac arrest. Eur. Heart J. 1999; 20(7): 535-540.
189. Kudenchuk, P.J., Cobb, L.A., Copass, M.K. Et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N. Engl. J. Med. 1999; 341(12): 871-878.
190. Dorian, P., Cass, D., Schwartz, B., Cooper, R., Gelaznikas, R., & Barr, A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N. Engl. J. Med. 2002; 346(12): 884-890.
191. Bernard, S.A., Gray, T.W., Buist, M.D. Et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.[comment]. N. Engl. J Med. 2002; 346(8): 557-563.
192. Anonymous. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. The Hypothermia after Cardiac Arrest Study Group.[erratum appears in N. Engl. J. Med. 2002 May 30; 346(22): 1756]. N. Engl. J. Med. 2002; 346(8): 549-556.
193. van der Hoeven, J., de Koning, J., van der Weyden, P., & Meinders, A. Improved outcome for patients with a cardiac arrest by supervision of the emergency medical services system. Netherlands J. Med. 1995; 46: 123-130.
194. Bergner, L., Bergner, M., Hallstrom, A.P., Eisenberg, M.S., & Cobb, L.A. Service factors and health status of survivors of out-of-hospital cardiac arrest. Am. J. Emerg. Med. 1983; 1(3): 259-263.
195. Frandsen, F., Nielsen, J.R., Gram, L. Et al. Evaluation of inten-sified prehospital treatment in out-of-hospital cardiac arrest: Survival and cerebral prognosis. The Odense Ambulance Study. Cardiology 1991; 79: 256-264.
196. Stiell, I.G., Wells, G.A., Field, B.J. Et al. Improved out-of-hospital cardiac arrest survival through the inexpensive opti-mization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life Support. J. Am. Med. Assoc. 1999; 281(13): 1175-1181.
197. Becker, L.B., Ostrander, M.P., Barrett, J., & Kondos, G.T. Outcomes of CPR in a large metropolitan area-where are the survivors? Ann. Emerg. Med. 1991; 20(4): 355-361.
198. Eckstein, M., Stratton, S.J., & Chan, L.S. Cardiac arrest resus-citation evaluation in Los Angeles: CARE-LA. Ann. Emerg. Med. 2005; 45(5): 504-509.
199. Cummins, R.O., Ornato, J.P., Thies, W.H., & Pepe, P.E. Improving survival from sudden cardiac arrest: The “chain of survival” concept. Circulation 1991; 83: 1832-1847.
200. Jacobs, I., Callanan, V., Nichol, G. Et al. The chain of survival. Ann. Emerg. Med. 2001; 37(4 Pt 2): S5-S16.
201. Hallstrom, A., Boutin, P., Cobb, L., & Johnson, E. Socioeconomic status and prediction of ventricular fibrilla-tion survival. Am. J. Public Health 1993; 83(2): 245-248.
202. Pell, J.P., Sirel, J., Marsden, A.K., & Cobbe, S.M. Sex differences in outcome following community-based cardiopulmonary arrest. Eur. Heart J. 2000; 21(3): 239-244.
203. Litwin, P.E., Eisenberg, M.S., Hallstrom, A.P., & Cummins, R.O. The location of collapse and its effect on survival from cardiac arrest. Ann. Emerg. Med. 1987; 16(7): 787-791.
204. Herlitz, J., Eek, M., Holmberg, M., Engdahl, J., & Holmberg, S. Characteristics and outcome among patients having out of hospital cardiac arrest at home compared with elsewhere. Heart 2002; 88(6): 579-582.
205. Weaver, W.D., Cobb, L.A., Hallstrom, A.P. Et al. Considerations for improving survival from out-of-hospital cardiac arrest. Ann. Emerg. Med. 1986; 15: 1181-1186.
206. Gray, W.A., Capone, R.J., & Most, A.S. Unsuccessful emer-gency medical resuscitation-are continued efforts in the emergency department justified? N. Engl. J. Med. 1991; 325(20): 1393-1398.
207. Kellermann, A., Hackman, B., & Somes, G. Predicting the outcome of unsuccessful prehospital advanced cardiac life support. J. Am. Med. Assoc. 1993; 270: 1433-1436.
208. Bonnin, M.J., Pepe, P.E., Kimball, K.T., & Clark, P.S. Distinct criteria for termination of resuscitation in the out-of-hospital setting. J. Am. Med. Assoc. 1993; 270: 1457-1462.
209. Beyersdorf, F., Kirsh, M., Buckberg, G.D., Allen, B.S., Bonchek, L.I., & Arom, K.V. Warm glutamate/aspartate-enriched blood cardioplegic solution for perioperative sudden death. J. Thorac. Cardiovasc. Surg. 1992; 104(4): 1141-1147.
210. Plaisance, P., Lurie, K.G., & Payen, D. Inspiratory impedance during active compression-decompression cardiopul-monary resuscitation: A randomized evaluation in patients in cardiac arrest. Circulation 2000; 101(9): 989-994.
211. Wolcke, B.B., Mauer, D.K., Schoefmann, M.F. Et al. Comparison of standard cardiopulmonary resuscitation versus the combi-nation of active compression-decompression cardiopul-monary resuscitation and an inspiratory impedance threshold device for out-of-hospital cardiac arrest. Circulation 2003; 108(18): 2201-2205.
212. Thayne, R.C., Thomas, D.C., Neville, J.D., & van Dellen, A. Use of an impedance threshold device improves short-term out-comes following out-of-hospital cardiac arrest. Resuscitation 2005; 67(1): 103-108.
213. Aufderheide, T., Pirallo, R.G., Provo, T.A., & Lurie, K.G. Clinical evaluation of an inspiratory impedance threshold device during standard cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest. Crit. Care Med. 2005; 33(4):
214. Bunch, T.J., White, R.D., Khan, A.H., & Packer, D.L. Impact of age on long-term survival and quality of life following out-of-hospital cardiac arrest. Crit. Care Med. 2004; 32(4): 963-967.
215. Hallstrom, A.P., Cobb, L.A., & Yu, B.H. Influence of comor-bidity on the outcome of patients treated for out-of-hospital ventricular fibrillation. Circulation 1996; 93(11): 2019-2022.
216. Mahapatra, S., Bunch, T.J., White, R.D., Hodge, D.O., & Packer, D.L. Sex differences in outcome after ventricular fibrillation in out-of-hospital cardiac arrest. Resuscitation 2005; 65(2): 197-202.
217. Kim, C., Fahrenbruch, C.E., Cobb, L.A., & Eisenberg, M.S. Out-of-hospital cardiac arrest in men and women. Circulation 2001; 104(22): 2699-2703.
218. Cowie, M.R., Fahrenbruch, C.E., Cobb, L.A., & Hallstrom, A.P. Out-of-hospital cardiac arrest: Racial differences in outcome in Seattle. Am. J. Public Health 1993; 83(7): 955-959.
219. Kouwenhoven, W.B., Jude, J.R., & Knickerbocker, G.G. Closed-chest cardiac massage. J. Am. Med. Assoc. 1960; 173: 1064-1067.
220. Thompson, R.G., Hallstrom, A.P., & Cobb, L.A. Bystander-ini-tiated cardiopulmonary resuscitation in the management of ventricular fibrillation. Ann. Intern. Med. 1979; 90(5): 737-740.
221. Herlitz, J., Ekstrom, L., Wennerblom, B., Axelsson, A., Bang, A., & Holmberg, S. Effect of bystander initiated cardiopulmonary resuscitation on ventricular fibrillation and survival after wit-nessed cardiac arrest outside hospital. Br. Heart J. 1994; 72: 408-412.
222. Demirovic, J. Cardiopulmonary resuscitation programs revis-ited: Results of a community study among older African Americans. Am. J. Geriatr. Cardiol. 2004; 13(4): 182-187.
223. Lynch, B., Einspruch, E.L., Nichol, G., Becker, L.B., Aufderheide, T.P., & Idris, A. Effectiveness of a 30-min CPR self-instruction program for lay responders: A controlled ran-domized study. Resuscitation 2005; 67(1): 31-43.
224. Hallstrom, A.P., Ornato, J.P., Weisfeldt, M. Et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N. Engl. J. Med. 2004; 351(7): 637-646.
225. De Maio, V.J., Stiell, I.G., Wells, G.A., & Spaite, D.W. Cardiac arrest witnessed by emergency medical services personnel: Descriptive epidemiology, prodromal symptoms, and predic-tors of survival. OPALS study group. Ann. Emerg. Med. 2000; 35(2): 138-146.
226. Larsen, M.P., Eisenberg, M.S., Cummins, R.O., & Hallstrom, A.P. Predicting survival from out-of-hospital cardiac arrest: A graphic model. Ann. Emerg. Med. 1993; 22(11): 1652-1658.
227. Valenzuela, T., Roe, D.J., Cretin, S., Spaite, D.W., & Larsen, M.P. Estimating effectiveness of cardiac arrest interventions: A logistic regression survival model. Circulation 1997; 96: 3308-3313.
228. Pepe, P.E., Mattox, K.L., Duke, J.H., Fisher, P.B., & Prentice, F.D. Effect of full-time, specialized physician supervision on the success of a large, urban emergency medical services system. Crit. Care Med. 1993; 21(9): 1279-1286.
229. Wik, L., Kramer-Johansen, J., Myklebust, H. Et al. Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest. J. Am. Med. Assoc. 2005; 293(3): 299-304.
230. Abella, B.S., Alvarado, J.P., Myklebust, H. Et al. Quality of car-diopulmonary resuscitation during in-hospital cardiac arrest. J. Am. Med. Assoc. 2005; 293(3): 305-310.
231. Abella, B.S., Sandbo, N., Vassilatos, P. Et al. Chest compression rates during cardiopulmonary resuscitation are suboptimal: A prospective study during in-hospital cardiac arrest. Circulation 2005; 111(4): 428-434.